Lumentum to Join Nasdaq-100 Index Replacing CoStar Group
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 32 minutes ago
0mins
Should l Buy CSGP?
Source: Newsfilter
- Index Change Announcement: Lumentum Holdings Inc. will join the Nasdaq-100 Index on May 18, 2026, replacing CoStar Group, which is expected to enhance Lumentum's market visibility and investor confidence.
- Index Influence: The Nasdaq-100 Index includes 100 of the largest non-financial companies and manages over $600 billion in assets, and Lumentum's inclusion may attract more investment products tracking this index, thereby improving its liquidity and market performance.
- Market Reaction Anticipation: As a component of Nasdaq, Lumentum is likely to benefit from broader market recognition, particularly in the technology and capital markets, potentially driving its stock price higher.
- Investor Attention: Nasdaq Global Indexes offers over 35,000 indexes, and Lumentum's addition will increase its visibility among investors, potentially facilitating future capital raising and business expansion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CSGP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CSGP
Wall Street analysts forecast CSGP stock price to rise
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 34.980
Low
48.00
Averages
74.92
High
101.00
Current: 34.980
Low
48.00
Averages
74.92
High
101.00
About CSGP
CoStar Group, Inc. is a provider of online real estate marketplaces, information, analytics, and three-dimensional (3D) digital twin technology in the property markets. The Company operates through two segments, which include Commercial Real Estate and Residential Real Estate. Its Commercial Real Estate segment offers commercial real estate information and analytics, online marketplaces, and 3D digital twin technology. Its brands include CoStar and LoopNet. Its CoStar offers subscription-based access to its platform of commercial real estate intelligence. Its LoopNet is a commercial real estate marketing site which enables property owners, landlords, and brokers to advertise properties for sale or lease on a site. Its Residential Real Estate segment hosts marketplaces which aggregate consumer demand for homes to rent or buy and sell marketing and leads to the agents, owners, landlords, and property management companies to reach consumers with offerings.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Lumentum to Join Nasdaq-100 Index Replacing CoStar Group
- Index Change Announcement: Lumentum Holdings Inc. will join the Nasdaq-100 Index on May 18, 2026, replacing CoStar Group, which is expected to enhance Lumentum's market visibility and investor confidence.
- Index Influence: The Nasdaq-100 Index includes 100 of the largest non-financial companies and manages over $600 billion in assets, and Lumentum's inclusion may attract more investment products tracking this index, thereby improving its liquidity and market performance.
- Market Reaction Anticipation: As a component of Nasdaq, Lumentum is likely to benefit from broader market recognition, particularly in the technology and capital markets, potentially driving its stock price higher.
- Investor Attention: Nasdaq Global Indexes offers over 35,000 indexes, and Lumentum's addition will increase its visibility among investors, potentially facilitating future capital raising and business expansion.
See More
Lumentum to Join Nasdaq-100 Index, Replacing CoStar Group
- Component Change: Lumentum Holdings Inc. will become a new component of the Nasdaq-100 Index on May 18, 2026, replacing CoStar Group, Inc., highlighting Lumentum's significance and influence in the market.
- Index Impact: The Nasdaq-100 Index tracks 100 of the largest non-financial companies, managing over $600 billion in assets, and Lumentum's inclusion may attract more investor attention, enhancing its market liquidity and visibility.
- Nasdaq Global Indexes: Nasdaq Global Indexes offers over 35,000 indexes across various asset classes and geographies, and Lumentum's addition further diversifies and represents the index, potentially impacting the performance of related investment products.
- Market Reaction Expectations: With Lumentum's inclusion, the market may develop positive expectations regarding its future performance, prompting investors to reassess its position in the photonics industry, which could drive its stock price upward.
See More
Office Sector Dominates UK Investment in Q1 2026
- Decline in Total Investment: UK commercial property investment totaled £9.7 billion in Q1 2026, less than half of the previous quarter's volume, indicating a significant drop in market activity, particularly as US investors' large-scale healthcare investments failed to continue.
- Office Sector Leads: Office investment reached £2.9 billion, accounting for 30% of total investment, concentrated in London and a few key regional cities, reflecting sustained demand for quality office space despite overall market weakness.
- Weak Industrial and Retail Investment: Industrial investment totaled £1.8 billion, marking the lowest quarterly performance in nearly six years, while retail investment fell to £1.2 billion, halved from the previous quarter, highlighting challenges in consumer confidence and market conditions.
- Hotel Investment Under Pressure: Hotel investment also stood at £1.2 billion, but rising energy costs and geopolitical uncertainty present significant near-term headwinds, potentially impacting future investment decisions.
See More
Avalyn Pharma and CoStar Group Executives Increase Stock Holdings
- Avalyn Pharma Buy: Jill Carroll of Avalyn Pharma made a notable insider purchase on Friday, acquiring 277,778 shares at $18.00 each for a total of $5.00 million, which resulted in a 70.4% gain at the peak of trading, indicating strong confidence in the company's future performance.
- Price Volatility Impact: Despite Avalyn Pharma reaching a high of $30.67 during Monday's trading, the stock was down approximately 2.9% on the day, reflecting the complexities of market sentiment and short-term volatility surrounding the stock.
- CoStar Group Purchase: CEO Andrew C. Florance also made a significant insider buy on Friday, purchasing 71,430 shares at $35.20 each for a total of $2.51 million, marking his second purchase in the past year and demonstrating confidence in the company's long-term growth prospects.
- Historical Trade Comparison: Prior to this, Florance bought 248,000 shares at $44.52 each, indicating his sustained optimism about the company's value, even as the current stock price has declined, with a slight increase of about 0.5% on Monday's trading session.
See More
CoStar Group CEO's Stock Purchase Boosts Shares
- CEO Stock Purchase: CoStar Group's CEO Andy Florance purchased $2.5 million worth of stock on Friday, acquiring 68,330 shares at an average price of $35.17 and 3,100 shares at $35.82, indicating strong confidence in the company's future.
- Price Recovery: Following Florance's purchases, CoStar Group's stock rose 2.8% in premarket trading on Monday, reflecting market trust in management and a reassessment of the company's value.
- Shareholder Structure Change: Florance now holds 1.72 million shares, representing about 0.4% of the company's total 408.4 million shares outstanding, demonstrating his commitment to the company's long-term growth.
- Market Performance Comparison: Over the past year, CoStar Group's stock has dropped 54%, while the S&P 500 has risen by 29%, highlighting the company's relative weakness in the market, with the stock purchase potentially aimed at stabilizing investor confidence.
See More
UK Hotel Industry Sees RevPAR Growth
- RevPAR Increase: In Q1 2026, the UK hotel industry's revenue per available room (RevPAR) rose by 1.2% year-on-year, despite flat occupancy rates, indicating support from events in regional markets like Glasgow, Manchester, Cardiff, and Birmingham.
- Decline in Travel Spending: The Barclays UK Consumer Spend Report revealed that travel spending fell in March for the first time in five years, with year-on-year declines across travel agents, airlines, and public transport, potentially impacting the overall recovery of the tourism sector.
- Surge in Domestic Travel: Cancellations of overseas travel plans led to a spike in demand for domestic staycations over the Easter weekend, although rate growth remains challenging, which could provide support for future tourism recovery.
- Future Outlook: Stronger demand from British travelers is expected to bolster key UK tourist destinations, particularly during the summer, while London may face greater challenges due to its reliance on international and long-haul travel.
See More
Lumentum to Join Nasdaq-100 Index Replacing CoStar Group
- Index Change Announcement: Lumentum Holdings Inc. will join the Nasdaq-100 Index on May 18, 2026, replacing CoStar Group, which is expected to enhance Lumentum's market visibility and investor confidence.
- Index Influence: The Nasdaq-100 Index includes 100 of the largest non-financial companies and manages over $600 billion in assets, and Lumentum's inclusion may attract more investment products tracking this index, thereby improving its liquidity and market performance.
- Market Reaction Anticipation: As a component of Nasdaq, Lumentum is likely to benefit from broader market recognition, particularly in the technology and capital markets, potentially driving its stock price higher.
- Investor Attention: Nasdaq Global Indexes offers over 35,000 indexes, and Lumentum's addition will increase its visibility among investors, potentially facilitating future capital raising and business expansion.
See More
Lumentum to Join Nasdaq-100 Index, Replacing CoStar Group
- Component Change: Lumentum Holdings Inc. will become a new component of the Nasdaq-100 Index on May 18, 2026, replacing CoStar Group, Inc., highlighting Lumentum's significance and influence in the market.
- Index Impact: The Nasdaq-100 Index tracks 100 of the largest non-financial companies, managing over $600 billion in assets, and Lumentum's inclusion may attract more investor attention, enhancing its market liquidity and visibility.
- Nasdaq Global Indexes: Nasdaq Global Indexes offers over 35,000 indexes across various asset classes and geographies, and Lumentum's addition further diversifies and represents the index, potentially impacting the performance of related investment products.
- Market Reaction Expectations: With Lumentum's inclusion, the market may develop positive expectations regarding its future performance, prompting investors to reassess its position in the photonics industry, which could drive its stock price upward.
See More
Office Sector Dominates UK Investment in Q1 2026
- Decline in Total Investment: UK commercial property investment totaled £9.7 billion in Q1 2026, less than half of the previous quarter's volume, indicating a significant drop in market activity, particularly as US investors' large-scale healthcare investments failed to continue.
- Office Sector Leads: Office investment reached £2.9 billion, accounting for 30% of total investment, concentrated in London and a few key regional cities, reflecting sustained demand for quality office space despite overall market weakness.
- Weak Industrial and Retail Investment: Industrial investment totaled £1.8 billion, marking the lowest quarterly performance in nearly six years, while retail investment fell to £1.2 billion, halved from the previous quarter, highlighting challenges in consumer confidence and market conditions.
- Hotel Investment Under Pressure: Hotel investment also stood at £1.2 billion, but rising energy costs and geopolitical uncertainty present significant near-term headwinds, potentially impacting future investment decisions.
See More
Avalyn Pharma and CoStar Group Executives Increase Stock Holdings
- Avalyn Pharma Buy: Jill Carroll of Avalyn Pharma made a notable insider purchase on Friday, acquiring 277,778 shares at $18.00 each for a total of $5.00 million, which resulted in a 70.4% gain at the peak of trading, indicating strong confidence in the company's future performance.
- Price Volatility Impact: Despite Avalyn Pharma reaching a high of $30.67 during Monday's trading, the stock was down approximately 2.9% on the day, reflecting the complexities of market sentiment and short-term volatility surrounding the stock.
- CoStar Group Purchase: CEO Andrew C. Florance also made a significant insider buy on Friday, purchasing 71,430 shares at $35.20 each for a total of $2.51 million, marking his second purchase in the past year and demonstrating confidence in the company's long-term growth prospects.
- Historical Trade Comparison: Prior to this, Florance bought 248,000 shares at $44.52 each, indicating his sustained optimism about the company's value, even as the current stock price has declined, with a slight increase of about 0.5% on Monday's trading session.
See More
CoStar Group CEO's Stock Purchase Boosts Shares
- CEO Stock Purchase: CoStar Group's CEO Andy Florance purchased $2.5 million worth of stock on Friday, acquiring 68,330 shares at an average price of $35.17 and 3,100 shares at $35.82, indicating strong confidence in the company's future.
- Price Recovery: Following Florance's purchases, CoStar Group's stock rose 2.8% in premarket trading on Monday, reflecting market trust in management and a reassessment of the company's value.
- Shareholder Structure Change: Florance now holds 1.72 million shares, representing about 0.4% of the company's total 408.4 million shares outstanding, demonstrating his commitment to the company's long-term growth.
- Market Performance Comparison: Over the past year, CoStar Group's stock has dropped 54%, while the S&P 500 has risen by 29%, highlighting the company's relative weakness in the market, with the stock purchase potentially aimed at stabilizing investor confidence.
See More
UK Hotel Industry Sees RevPAR Growth
- RevPAR Increase: In Q1 2026, the UK hotel industry's revenue per available room (RevPAR) rose by 1.2% year-on-year, despite flat occupancy rates, indicating support from events in regional markets like Glasgow, Manchester, Cardiff, and Birmingham.
- Decline in Travel Spending: The Barclays UK Consumer Spend Report revealed that travel spending fell in March for the first time in five years, with year-on-year declines across travel agents, airlines, and public transport, potentially impacting the overall recovery of the tourism sector.
- Surge in Domestic Travel: Cancellations of overseas travel plans led to a spike in demand for domestic staycations over the Easter weekend, although rate growth remains challenging, which could provide support for future tourism recovery.
- Future Outlook: Stronger demand from British travelers is expected to bolster key UK tourist destinations, particularly during the summer, while London may face greater challenges due to its reliance on international and long-haul travel.
See More
